Obesity
GLP-1 usage surges in US
Revolutionary medicines appear to usher in new hope, helping people overcome obesity
For the first time in years, the U.S. obesity rate has ticked downward, from a high of nearly 40% in 2022 to 37% in 2025. While this change may seem modest, it marks a turning point in a troubling decades-long trend. So, what’s behind the shift? Many experts point to the growing use of GLP-1 medications like Ozempic, Wegovy, and Zepbound, drugs originally designed for diabetes management that are now helping millions of Americans shed excess weight and improve their overall health.
GLP-1 stands for glucagon-like peptide-1, a hormone that the human body naturally produces after eating. This helps regulate blood sugar and signals to your brain that you’re full. GLP-1 drugs mimic this hormone, helping people feel satisfied sooner and reduce cravings. In more simple terms, GLP-1 medications help people eat less without feeling deprived. This is a big deal, especially for people who’ve struggled to achieve weight loss.
A Shift in the Numbers
According to a recent Gallup survey, 12% of U.S. adults now report having used a GLP-1 medication. This is double the rate that was measured in 2024. The survey also found that awareness of GLP-1 medications is growing, with nearly half of U.S. adults saying they’ve heard of these drugs.
Usage is especially common among adults aged 45 to 64, those with higher income levels, and individuals with private insurance. This highlights some of the access challenges still persist in obesity treatment.
More Than Just Weight Loss
While shedding pounds is a key benefit, GLP-1 drugs may also help improve overall health. Obesity is linked to conditions like heart disease, diabetes, and sleep apnea. By helping people lose weight, these medications could reduce the risk of these chronic illnesses. Accordingly, Some GLP-1 users also report feeling more energetic, sleeping better, and experiencing fewer food cravings. For many, it’s not just about the number on the scale, it’s about feeling better in their bodies, more in control of their health, and more present in the lives of loved ones (and with greater optimism about the future).
Even with such positivity about the impact of these medicines, it’s important to note that GLP-1 drugs aren’t a quick fix. They work best when combined with healthy habits like balanced eating, physical activity, and stress management. And they may not be suitable for everyone. Some users experience side effects like nausea or digestive issues, while others may not be eligible due to co-existing medical conditions.
Changing the Conversation
Another impactful effect of GLP-1 drugs is how they’ve helped change the way society views obesity. For years, weight loss was framed as a simple matter of willpower: eat less, move more, and the pounds should just melt away. But science now tells us that obesity is a complex condition influenced by genetics, hormones, environment, and more.
GLP-1 medications highlight the biological side of weight regulation. They show that for many people, hunger and satiety aren’t just about choice, they’re about body chemistry. And that shift in understanding can lead to more compassion, better treatment, and less stigma.
Looking Ahead
As research advances and more people gain access to GLP-1s, there may be further changes in both obesity rates and public health outcomes. Researchers continue to explore how these drugs affect metabolism, brain function, and long-term weight maintenance. There’s even interest in using them to treat conditions like addiction and Alzheimer’s disease.
For now, the early results are promising. People who’ve struggled with weight for years are finding new hope, and that’s worth celebrating.
If you’re curious about these medications, talk to your healthcare provider. They can help you understand the risks, benefits, and what may be a good fit for personal health goals. You can also research nearby clinical trials of these medicines.
Published Date November 06, 2025
Latest News
Obesity
GLP-1 usage surges in US
Revolutionary medicines appear to usher in new hope, helping people overcome obesity
2025-11-06T20:58:00Z
Inflammatory Bowel Disease (IBD)
Ulcerative Colitis vs. Crohn’s Disease - what's the difference?
IBD comes in two primary forms with similar, unpleasant symptoms, but different management and treatment approaches
2025-10-28T16:55:00Z
Hypertension
Smartwatches getting smarter for better heart health
Smartwatches advance through innovation to identify risk of high blood pressure
2025-09-22T20:46:00Z
Inflammatory Bowel Disease (IBD)
Diet and IBD: eat this, not that
Making lifestyle changes, especially dietary changes, can help limit or lessen flare-ups of IBD
2025-09-19T20:46:00Z
Heart Disease
Genetics and Heart Disease: understanding personal risk
As the scientific community learns more about genetic variants, links to disease onset become clearer
2025-09-17T16:39:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
From NASH to MASH: a meaningful name change
What's in a name? A lot when it comes to engaging patients in care options
2025-09-09T12:19:00Z
Heart Disease
GLP-1: more than a weight loss drug
GLP-1 medicines may be an exciting new frontier for heart disease treatment
2025-08-26T15:35:00Z
Diabetes
Participating in clinical research from your home
A DCT brings cutting-edge research fueled by digital innovation straight into a person's home for utmost convenience
2025-08-05T17:23:00Z
Non-Hodgkin Lymphoma
The ABCs of blood cells and blood cancers: Lymphoma
Every blood cell has an important job to do but sometimes cancer gets in the way
2025-06-13T17:22:00Z
Non-Hodgkin Lymphoma
How dogs are helping advance lymphoma research
Dogs are furry and faithful companions that too can face cancer - learn how some are benefiting from medical research
2025-05-28T17:36:00Z
Melanoma
Melanoma: Separating Myths from Facts
Melanoma is a serious form of cancer yet many myths persist around what it is, where it is, and who is at risk
2025-04-28T21:05:00Z
Melanoma
Advances in Melanoma Treatment
Clinical research is helping bring new, and much-needed, treatments to market
2025-04-15T21:17:00Z
Asthma
New thinking in childhood asthma diagnosis approach
New studies show that over-calculating race risk in asthma diagnostic tools may actually delay diagnosis
2025-03-21T13:51:00Z
Alzheimer's Disease
As America ages, dementia diagnoses poised to double
With humans living longer due to medical breakthroughs, the chance of developing dementia has greatly increased
2025-02-19T13:56:00Z
Multiple Sclerosis (MS)
Is lassitude affecting your attitude?
The extreme fatigue of MS is so unrelenting that it has its own name: lassitude. What can you do to try and improve this feeling?
2025-01-24T18:58:00Z
Asthma
Breathing easy: the work of an asthma inhaler
Inhalers are lifechanging for people living with asthma and other breathing difficulties
2025-01-07T17:33:00Z
Leukemia (AML)
A simple guide to understanding chemo
Chemo is an effective cancer treatment - but what is it exactly and why does it work?
2024-12-09T14:25:00Z
Eczema
Self-care tips during eczema flare-ups
Eczema can be emotionally draining and physically uncomfortable - learn how self-care can change your outlook
2024-11-26T18:46:00Z
Healthy Volunteers
What is a Phase 1 trial?
Phase 1 trials are necessary first steps on the road to clinical breakthroughs and healthy volunteers can help make these a reality.
2024-11-11T15:35:00Z
Colorectal Cancer
The role of biomarker testing in cancer
Biomarkers can play important roles in cancer treatment, but what are they and what can they tell doctors?
2024-10-16T18:18:00Z
Hypertension
Home-based exercise tips for blood pressure control
Getting heart-healthy physical activity doesn't have to mean running a marathon or joining an expensive gym.
2024-09-08T18:30:00Z
Leukemia (AML)
What helps with nausea besides medicine?
Nausea is an unfortunate aspect of cancer treatment - what may help reduce this side effect?
2024-08-31T18:30:00Z
Healthy Volunteers
Common misconceptions about clinical research
Many people have never participated in a clinical trial so it can be hard to separate fact from myth - here are some of the most common myths debunked.
2024-08-28T21:23:00Z
Obesity
The basics of BMI
BMI, or Body Mass Index, is a standard way to assess weight status - learn why and where it came from
2024-08-22T13:50:00Z
Colorectal Cancer
Why is Colorectal Cancer striking at younger ages?
The number of people being diagnosed with colorectal cancer under the age of 50 has greatly increased - what might be the cause of this troubling trend?
2024-08-14T16:12:00Z
Hypertension
Four foods linked with lower blood pressure
While the foods you eat can raise the risk of developing hypertension, there are also options that can help lower blood pressure.
2024-08-01T18:30:00Z
Obesity
A primer on GLP-1 receptor agonists for weight loss
An overview on select GLP-1 receptor agonist treatments that help promote blood sugar management and weight loss
2024-07-31T18:30:00Z
Multiple Myeloma
Life with a rare disease
Experiencing serious health challenges is difficult enough - having a relatively unknown condition adds additional complexity
2024-07-08T22:02:00Z
Eczema
Atopic Dermatitis: signs and stages
Understanding how atopic dermatitis looks, feels and changes during a flare-up is helpful to patients seeking greater control of their condition
2024-07-01T16:12:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Speaking with your PCP about MASH
Engaging your primary doctor in a conversation about risk for MASH liver disease doesn't have to be scary
2024-06-25T12:15:00Z
Alzheimer's Disease
New Alzheimer’s Disease research breakthroughs
The 2020s have been the most impactful decade so far for the debilitating form of dementia
2024-05-02T18:30:00Z
Breast Cancer
Talking to family about cancer genes
Though this conversation may be difficult, it might be vitally important for your loved ones
2024-02-05T18:30:00Z
Lupus
Lupus (Systemic Lupus Erythematosus) and Diet
Can what you eat make a difference?
2024-04-15T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Learning you need a liver biopsy: staying calm
Approaches to stay in control before, during and after a biopsy
2023-12-27T18:30:00Z
Diabetes
The recent rise of walking as exercise
Grab your sneakers, grab a friend, or grab your dog and get moving!
2023-12-05T18:30:00Z
Renal Cell Carcinoma
Coping with the holidays during cancer treatment
Getting ready to face a new year while facing cancer is no easy task
2023-11-23T18:30:00Z
Multiple Sclerosis (MS)
Possible link between multiple sclerosis and viral infection?
Researchers are looking to learn more about if and how a virus can trigger multiple sclerosis
2023-10-25T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Losing excess weight together with an active lifestyle helps with the management of MASH, but where to begin?
2023-09-05T18:30:00Z
Lung Cancer
Talking to loved ones about your clinical trial
How to talk to family and friends when you are thinking of changing cancer treatment plans for a research option
2023-08-14T18:30:00Z
Lung Cancer
Learning you have lung cancer as a non-smoker
Lung cancer can be a shocking diagnosis when you've never smoked - how can it be?
2023-08-15T18:30:00Z
Prostate Cancer
Does a high PSA score always mean cancer?
Learn more about this common test for older men and how it relates to cancer risk
2023-07-10T18:30:00Z
Breast Cancer
Understanding the differences between mastectomy and lumpectomy
Two different surgical options both seeking the same outcome
2023-07-07T18:30:00Z
Lupus
New treatments are on the horizon for lupus patients
From biologics to CAR-T, developments in clinical research for SLE have opened new treatment doors for patients.
2023-05-22T16:15:00Z
Multiple Myeloma
Understanding eligibility criteria for clinical research studies
Clinical trials utilize sets of criteria to determine if a person is a good fit - but what are these and what do they mean?
2023-04-05T18:30:00Z
Renal Cell Carcinoma
Learning you need a biopsy: staying calm
Approaches to stay in control before, during and after a diagnostic biopsy
2023-03-14T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Pharmaceutical companies are rushing to fill the NASH treatment gap
2023-03-14T18:30:00Z